The Clinical Potential of Circulating Tumor Cells and Circulating Tumor-Associated Cellular Elements in Colorectal Cancer Judy S. WangMichael B. FooteLuis A. Diaz Jr Translational Colorectal Oncology (Y Jiang, Section Editor) 24 October 2013 Pages: 303 - 311
Oncotype DX for Colon Cancer: Are We Ready for Prime Time in Personalized Medicine? James J. LeeEdward Chu Translational Colorectal Oncology (Y Jiang, Section Editor) 14 September 2013 Pages: 312 - 316
Do We Need another Antiangiogenesis Agent for Colorectal Cancer: are Bevacizumab and Aflibercept the Same? Maria Ignez BraghiroliRachel P. RiechelmannPaulo M. Hoff Translational Colorectal Oncology (Y Jiang, Section Editor) 12 October 2013 Pages: 317 - 325
How Do We Make Choices in Salvage Therapy: Panitumumab, Cetuximab, or Regorafenib? Elena TsvetkovaTimothy R. Asmis Translational Colorectal Oncology (Y Jiang, Section Editor) 11 September 2013 Pages: 326 - 330
Role of Apoptosis in Colon Cancer Biology, Therapy, and Prevention Lin ZhangJian Yu Molecular Biology (S Anant, Section Editor) 01 October 2013 Pages: 331 - 340
Stem Cell Signaling Pathways in Colorectal Cancer B. S. RamakrishnaSam Vijay Kumar Molecular Biology (S Anant, Section Editor) 31 October 2013 Pages: 341 - 349
Reactive Oxygen Species and Colorectal Cancer Sandeep SreevalsanStephen Safe Molecular Biology (S Anant, Section Editor) 04 October 2013 Pages: 350 - 357
Honokiol as a Radiosensitizing Agent for Colorectal Cancers Zhiyun HeDharmalingam SubramaniamShrikant Anant Molecular Biology (S Anant, Section Editor) 04 October 2013 Pages: 358 - 364
Molecular Origins of Colon and Rectal Cancer: Not a Wnt–Wnt Situation Murali D. BashyamRatheesh Raman Molecular Biology (S Anant, Section Editor) 04 October 2013 Pages: 365 - 371
The Association of Immune Cell Infiltration and Prognosis in Colorectal Cancer Richard PalmqvistMaria L. WikbergSofia Edin Immunotherapy of Malignancy (MA Morse, Section Editor) 27 October 2013 Pages: 372 - 379
Status of Active Specific Immunotherapy for Stage II, Stage III, and Resected Stage IV Colon Cancer Vanessa DeschoolmeesterEvelien SmitsJan B. Vermorken Immunotherapy of Malignancy (MA Morse, Section Editor) 31 August 2013 Pages: 380 - 390
Modulation of Immune System Inhibitory Checkpoints in Colorectal Cancer Sandip P. PatelTakuya OsadaMichael A. Morse Immunotherapy of Malignancy (MA Morse, Section Editor) 13 August 2013 Pages: 391 - 397
Viral Vector Vaccines To Treat Colorectal Cancer N. AshrafA. MahipalR. Kim Immunotherapy of Malignancy (MA Morse, Section Editor) 14 August 2013 Pages: 398 - 405